Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Octreotide alone or with celecoxib for prevention and treatment of severe acute pancreatitis
ChiCTR-TRC-10000844Phase 4Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Aug 2010
- Modality
- Peptides, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of octreotide and celecoxib in acute pancreatitis (AP) (4 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Index of radioimmunity, Mortality and 7 more. Started Aug 2010; status: completed.
02
Drugs
octreotidecelecoxib
03
Conditions
acute pancreatitis (AP)
Beyond the preview
Go deeper on ChiCTR-TRC-10000844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-10000844.